scholarly article | Q13442814 |
P2093 | author name string | Rebecca J Gum | |
Jill E Clampit | |||
James M Trevillyan | |||
Roger G Ulrich | |||
Cristina M Rondinone | |||
Bradley A Zinker | |||
Lori L Gaede | |||
Matthew Heindel | |||
Michael R Jirousek | |||
Sandra L Koterski | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | preproinsulin | Q7240673 |
P304 | page(s) | 21-28 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice | |
P478 | volume | 52 |
Q36421324 | A high-selenium diet induces insulin resistance in gestating rats and their offspring |
Q47273752 | A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway |
Q36379383 | Adipose targets for obesity drug development |
Q24304908 | An enzyme-linked immunosorbent assay to measure insulin receptor dephosphorylation by PTP1B |
Q42976084 | Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice |
Q42972035 | Antidiabetic effects of total flavonoids from Litsea Coreana leve on fat-fed, streptozotocin-induced type 2 diabetic rats |
Q37199333 | Beyond insulin replacement: addressing the additional needs of the diabetes patient |
Q91832177 | Caulerpa lentillifera inhibits protein-tyrosine phosphatase 1B and protects pancreatic beta cell via its insulin mimetic effect |
Q42224366 | Chromium-containing traditional Chinese medicine, Tianmai Xiaoke Tablet improves blood glucose through activating insulin-signaling pathway and inhibiting PTP1B and PCK2 in diabetic rats |
Q28594157 | Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP |
Q73210876 | Current literature in diabetes |
Q34577123 | Dephosphorylation by default, a potential mechanism for regulation of insulin receptor substrate-1/2, Akt, and ERK1/2. |
Q42924743 | Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors |
Q33557864 | Discovery of novel PTP1B inhibitors with antihyperglycemic activity |
Q37332419 | Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis |
Q51359048 | Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice. |
Q42085317 | GSK-3β inhibition protects mesothelial cells during experimental peritoneal dialysis through upregulation of the heat shock response |
Q42063971 | GSK3beta Inhibitor Peptide Protects Mice from LPS-induced Endotoxin Shock |
Q33812730 | GSK3beta: role in therapeutic landscape and development of modulators |
Q34496413 | High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism |
Q37852704 | IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling. |
Q43291838 | Impact of selenite and selenate on differentially expressed genes in rat liver examined by microarray analysis |
Q34107651 | Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice |
Q37001171 | Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age |
Q50854047 | Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice. |
Q43193940 | Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice |
Q42826975 | Inhibition of protein tyrosine phosphatase 1B and regulation of insulin signalling markers by caffeoyl derivatives of chicory ( Cichorium intybus) salad leaves |
Q33707592 | Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue |
Q30468589 | Insulin receptor substrate 2 (IRS2)-deficient mice show sensorineural hearing loss that is delayed by concomitant protein tyrosine phosphatase 1B (PTP1B) loss of function |
Q37715179 | Insulin signaling meets mitochondria in metabolism |
Q42503440 | Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression |
Q45256105 | Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/-mice |
Q89811716 | Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence |
Q34031701 | Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training |
Q38593252 | Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction. |
Q41500970 | Molecular docking and virtual screening for novel protein tyrosine phosphatase 1B (PTP1B) inhibitors |
Q35126070 | Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress |
Q47329751 | Neuronal PTP1B regulates body weight, adiposity and leptin action. |
Q41818058 | Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues |
Q39594207 | New emerging role of protein-tyrosine phosphatase 1B in the regulation of glycogen metabolism in basal and TNF-α-induced insulin-resistant conditions in an immortalised muscle cell line isolated from mice. |
Q43299789 | New mechanisms by which physical exercise improves insulin resistance in the skeletal muscle |
Q88197309 | Norathyriol reverses obesity- and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B |
Q38259507 | Novel therapeutics for type 2 diabetes: insulin resistance |
Q48171497 | Omentectomy Prevents Metabolic Syndrome By Reducing Appetite and Body Weight In A Diet-Induced Obesity Rat Model |
Q37992232 | PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis |
Q37485003 | Peripheral nervous system insulin resistance in ob/ob mice. |
Q38723618 | Promising Inhibitory Effects of Anthraquinones, Naphthopyrone, and Naphthalene Glycosides, from Cassia obtusifolia on α-Glucosidase and Human Protein Tyrosine Phosphatases 1B. |
Q37614594 | Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy? |
Q36662772 | Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo |
Q40177903 | Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance |
Q36003873 | Protein-tyrosine phosphatases are involved in interferon resistance associated with insulin resistance in HepG2 cells and obese mice |
Q35688217 | Recent advances in protein tyrosine phosphatase 1B inhibitors |
Q40127873 | Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin |
Q38303815 | Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice |
Q35049153 | Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats |
Q54378456 | Rosiglitazone attenuates tumor necrosis factor-α-induced protein-tyrosine phosphatase-1B production in HepG2 cells. |
Q38937256 | Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells. |
Q27652187 | Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24 |
Q37653296 | Sustained high protein-tyrosine phosphatase 1B activity in the sperm of obese males impairs the sperm acrosome reaction |
Q45255796 | Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors |
Q34162283 | Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases |
Q39119938 | Targeting density-enhanced phosphatase-1 (DEP-1) with antisense oligonucleotides improves the metabolic phenotype in high-fat diet-fed mice |
Q52549011 | Telomerase - strategies to exploit an important chemotherapeutic target. |
Q28587753 | The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice |
Q35143897 | The potential of antisense as a CNS therapeutic |
Q37805797 | Tissue specificity on insulin action and resistance: past to recent mechanisms. |
Q44805566 | Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action |
Q36806514 | Treating insulin resistance: future prospects. |
Q52338593 | Ursolic Acid Hydrazide Based Organometallic Complexes: Synthesis, Characterization, Antibacterial, Antioxidant, and Docking Studies. |
Q35151318 | Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants |
Search more.